Genetic identification of familial hypercholesterolemia within a single US health care system

被引:308
作者
Abul-Husn, Noura S. [1 ]
Manickam, Kandamurugu [2 ]
Jones, Laney K. [2 ]
Wright, Eric A. [2 ]
Hartzel, Dustin N. [2 ]
Gonzaga-Jauregui, Claudia [1 ]
O'Dushlaine, Colm [1 ]
Leader, Joseph B. [2 ]
Kirchner, H. Lester [2 ]
Lindbuchler, D'Andra M. [2 ]
Barr, Marci L. [2 ]
Giovanni, Monica A. [2 ]
Ritchie, Marylyn D. [2 ]
Overton, John D. [1 ]
Reid, Jeffrey G. [1 ]
Metpally, Raghu P. R. [2 ]
Wardeh, Amr H. [2 ]
Borecki, Ingrid B. [1 ]
Yancopoulos, George D. [1 ]
Baras, Aris [1 ]
Shuldiner, Alan R. [1 ]
Gottesman, Omri [1 ]
Ledbetter, David H. [2 ]
Carey, David J. [2 ]
Dewey, Frederick E. [1 ]
Murray, Michael F. [2 ]
机构
[1] Regeneron Genet Ctr, Tarrytown, NY 10591 USA
[2] Geisinger Hlth Syst, Danville, PA 17822 USA
关键词
ASSOCIATION EXPERT PANEL; GENERAL-POPULATION; PREVALENCE; MANAGEMENT; DIAGNOSIS; RECOMMENDATIONS; CHOLESTEROL; VARIANTS; GENOME; GUIDELINES;
D O I
10.1126/science.aaf7000
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Familial hypercholesterolemia (FH) remains underdiagnosed despite widespread cholesterol screening. Exome sequencing and electronic health record (EHR) data of 50,726 individuals were used to assess the prevalence and clinical impact of FH-associated genomic variants in the Geisinger Health System. The estimated FH prevalence was 1: 256 in unselected participants and 1: 118 in participants ascertained via the cardiac catheterization laboratory. FH variant carriers had significantly increased risk of coronary artery disease. Only 24% of carriers met EHR-based presequencing criteria for probable or definite FH diagnosis. Active statin use was identified in 58% of carriers; 46% of statin-treated carriers had a low-density lipoprotein cholesterol level below 100 mg/dl. Thus, we find that genomic screening can prompt the diagnosis of FH patients, most of whom are receiving inadequate lipid-lowering therapy.
引用
收藏
页数:7
相关论文
共 48 条
  • [1] Revisiting Wilson and Jungner in the genomic age:: a review of screening criteria over the past 40 years
    Andermann, Anne
    Blancquaert, Ingeborg
    Beauchamp, Sylvie
    Dery, Veronique
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2008, 86 (04) : 317 - 319
  • [2] [Anonymous], 1991, BMJ, V303, P893
  • [3] The Precision Medicine Initiative A New National Effort
    Ashley, Euan A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (21): : 2119 - 2120
  • [4] Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review
    Austin, MA
    Hutter, CM
    Zimmern, RL
    Humphries, SE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) : 407 - 420
  • [5] Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217
    Benn, Marianne
    Watts, Gerald F.
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1384 - 1394
  • [6] Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
    Benn, Marianne
    Watts, Gerald F.
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) : 3956 - 3964
  • [7] Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI [10.1056/NEJMra1312543, 10.1056/NEJMc1408914]
  • [8] Public Health Action in Genomics Is Now Needed beyond Newborn Screening
    Bowen, M. S.
    Kolor, K.
    Dotson, W. D.
    Ned, R. M.
    Khoury, M. J.
    [J]. PUBLIC HEALTH GENOMICS, 2012, 15 (06) : 327 - 334
  • [9] The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research
    Carey, David J.
    Fetterolf, Samantha N.
    Davis, Daniel
    Faucett, William A.
    Kirchner, H. Lester
    Mirshahi, Uyenlinh
    Murray, Michael F.
    Smelser, Diane T.
    Gerhard, Glenn S.
    Ledbetter, David H.
    [J]. GENETICS IN MEDICINE, 2016, 18 (09) : 906 - 913
  • [10] Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States
    Chen, Christina X.
    Hay, Joel W.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 : 417 - 424